Study of Aranesp to Treat Anemia in Prostate Cancer Patients.
Status:
Completed
Trial end date:
2005-02-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to see if darbepoetin alfa is an effective treatment for anemia
in prostate cancer patients and, if so, what dose is most effective. Sometimes prostate
cancer patients have low red blood cell counts (low hemoglobin) from various treatments they
are receiving, such as chemotherapy. The red blood cells deliver oxygen to the tissue. This
then helps give the patient more energy.